Literature DB >> 1706340

Conversion of cysteine to serine residues alters the activity, stability, and heparin dependence of acidic fibroblast growth factor.

S Ortega1, M T Schaeffer, D Soderman, J DiSalvo, D L Linemeyer, G Gimenez-Gallego, K A Thomas.   

Abstract

Acidic fibroblast growth factor (aFGF) is a broad spectrum mitogen that is stabilized by complexation with heparin and heparan proteoglycans. The monomeric human protein contains 3 reduced cysteine residues of unknown function, the first 2 of which are conserved among all seven known fibroblast growth factors. The influence of these free sulfhydryl groups on the level, stability, and heparin dependence of the mitogenic activity at physiological temperature and pH is characterized using a complete set of site-directed mutants in which either any 1, 2, or all 3 of the cysteine residues are converted to serines. Mutants of aFGF in which either any 2 or all 3 cysteine residues are substituted by serines are more active, have longer activity half-lives, and are less heparin dependent than wild-type aFGF. In contrast, wild-type aFGF and the three mutants that each retain 2 cysteine residues inactivate more rapidly in the absence of heparin by a nonproteolytic mechanism but are markedly stabilized by heparin. This cysteine-mediated destabilization of aFGF not only diminishes its activity in the absence of heparin in tissue culture but also could functionally restrict its activity in vivo to the vicinity of mast cell-derived heparins and heparan proteoglycans associated with cell surfaces and basement membranes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1706340

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Structure and stability effects of mutations designed to increase the primary sequence symmetry within the core region of a beta-trefoil.

Authors:  S R Brych; S I Blaber; T M Logan; M Blaber
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

2.  Accommodation of a highly symmetric core within a symmetric protein superfold.

Authors:  Stephen R Brych; Jaewon Kim; Timothy M Logan; Michael Blaber
Journal:  Protein Sci       Date:  2003-12       Impact factor: 6.725

Review 3.  The extracellular regulation of growth factor action.

Authors:  R Flaumenhaft; D B Rifkin
Journal:  Mol Biol Cell       Date:  1992-10       Impact factor: 4.138

4.  Redesigning symmetry-related "mini-core" regions of FGF-1 to increase primary structure symmetry: thermodynamic and functional consequences of structural symmetry.

Authors:  Vikash Kumar Dubey; Jihun Lee; Michael Blaber
Journal:  Protein Sci       Date:  2005-08-04       Impact factor: 6.725

Review 5.  Degradative covalent reactions important to protein stability.

Authors:  D B Volkin; H Mach; C R Middaugh
Journal:  Mol Biotechnol       Date:  1997-10       Impact factor: 2.695

6.  Engineering a Cysteine-Free Form of Human Fibroblast Growth Factor-1 for "Second Generation" Therapeutic Application.

Authors:  Xue Xia; Ozan S Kumru; Sachiko I Blaber; C Russell Middaugh; Ling Li; David M Ornitz; Mason A Sutherland; Connie A Tenorio; Michael Blaber
Journal:  J Pharm Sci       Date:  2016-04       Impact factor: 3.534

7.  Aggregation pathway of recombinant human keratinocyte growth factor and its stabilization.

Authors:  B L Chen; T Arakawa; C F Morris; W C Kenney; C M Wells; C G Pitt
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

8.  Formulation design of acidic fibroblast growth factor.

Authors:  P K Tsai; D B Volkin; J M Dabora; K C Thompson; M W Bruner; J O Gress; B Matuszewska; M Keogan; J V Bondi; C R Middaugh
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

9.  Engineering an improved crystal contact across a solvent-mediated interface of human fibroblast growth factor 1.

Authors:  Akshaya K Meher; Sachiko I Blaber; Jihun Lee; Ejiro Honjo; Ryota Kuroki; Michael Blaber
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-10-30

10.  Increased protein stability of FGF1 can compensate for its reduced affinity for heparin.

Authors:  Malgorzata Zakrzewska; Antoni Wiedlocha; Anna Szlachcic; Daniel Krowarsch; Jacek Otlewski; Sjur Olsnes
Journal:  J Biol Chem       Date:  2009-07-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.